The Biosim•Exchange: Canada’s trusted source for timely information on biosimilar biologics

About the Biosim•Exchange

Arthritis Consumer Experts (ACE) has been a leader in biosimilars policy development discussions since 2009, sharing information with stakeholders across Canada through free research-based workshops, webinars and education programs. Drawing from this experience, ACE has created the Biosim•Exchange, an information hub for consumers to get the latest biosimilar biologics news and background analysis.

With research-based information and education, patients can have a full therapy conversation with their rheumatologist (or other specialist) in order to best decide on their choice of medication, including originator biologic and biosimilar biologic.

Biosimilars should have a positive effect for both the healthcare system, and most importantly, inflammatory arthritis patients; they can broaden access for inflammatory arthritis patients who need advanced therapy and address the significant and growing cost of biologics.  

As biosimilars research data continues to be published and policies regulating them evolve, ACE is meeting with public and private drug plan decision makers to advocate for  biosimilar cost savings to be reinvested to improve models of care for patients living with complex chronic diseases.

Please share the Biosim•Exchange with other patients, your friends and family.

We look forward to your questions and comments and hearing about your experience with biosimilars.